期刊文献+

不同剂量和模式连续性肾脏替代治疗对氨基酸的清除 被引量:8

Comparative study of amino acids clearance between various doses and modes of continuous renal replacement therapy
下载PDF
导出
摘要 目的:比较不同剂量和模式连续性肾脏替代治疗(CRRT)对氨基酸的清除率。方法:4例需行CRRT治疗的急性肾损伤(AKI)患者,采用EdwardsCRRT机器进行治疗,治疗中每隔20min按如下模式进行切换:连续性血液静脉静脉透析(CVVHD)(2000ml/h和4000ml/h)、连续性静脉静脉血液滤过(CVVH)前稀释(2000ml/h和4000ml/h)、CVVH后稀释(2000ml/h和4000ml/h)。测定不同剂量及模式治疗时滤器前(置换液输入前)、滤器后、透析废液或超滤液中尿素氮(UN)、肌酐(Cr)和12种氨基酸的浓度,分别计算清除率及筛选系数(SC)。结果:天冬氨酸(Asp)和谷氨酸(Glu)的SC分别为0.5±0.04、0.48±0.07,其余10种氨基酸的SC均接近0.85。不同的剂量和模式下,UN与Cr的清除率基本相同;治疗剂量为2000ml/h时,UN和Cr在CVVHD、CVVH前稀释和CVVH后稀释模式下的清除率分别为32.7/32.68ml/min、23.95/24.69ml/min、32.62/32.22ml/min;剂量为4000ml/h时,上述三种模式的清除率分别为62.73/63.31ml/min、45.59/48.09ml/min、65.16/66.41ml/min;除了Asp和Glu,其余10种氨基酸清除率较为接近。剂量为2000ml/h时,在CVVHD、CVVH前稀释和CVVH后稀释模式下Asp和Glu的清除率分别为18.08和16.79ml/min、13.39和13.33ml/min、19.10和19.58ml/min;其余10种氨基酸的清除率分别为28.31~32.18ml/min、21.64~24.9ml/min、27.28~32.38ml/min。剂量为4000ml/h时,在上述三种模式下Asp和Glu的清除率分别为36.95和32.88ml/min、29.37和26.86ml/min、37.82和34.79ml/min;其余10种氨基酸清除率分别为59.18~64.8ml/min、46.71~50.64ml/min、58.83~65.1ml/min。结论:不同透析模式对氨基酸清除率存在一定影响,但不同治疗剂量对其影响更明显。 Objective: To evaluate the effects of different modes and doses of continuous renal replacement therapy (CRRT) on the clearance of amino acids. Methodology:Four patients requiring CRRT due to acute kidney injury were enrolled in this study. An Edward CRRT machine and AV-600 filter was used for CRRT. During each treatment session, the CRRT mode and dose was switched as following order every 20 minutes:continuous veno-venous hemodialysis (CVVHD) 2 000 ml/h ,4 000 ml/h, continuous veno-venons hemofiltration(CVVH) through pre-dilution route (pre-CVVH) 2 000 ml/ h ,4 000 ml/h, CVVH through post-dilution route (post-CVVH)2 000 ml/h,4 000 ml/h. Each time before the switching of mode or dose,the blood samples were drawn from the pre-filter site (before replacement fluid infusion in pre-CVVH mode) and post-filter site, as well as effluent samples. All specimens were measured for urea nitrogen (UN) , creatinine (Cr) , 5essential amino acids ( Valine, Methionine, Isoleucine, Leucine, Lysine) ,2 semi-essential amino acids ( Arginine, Histidine), and 5 non-essential amino acids ( Aspartic acid, Glumatic acid, Glycine, Citrulline, Ornithine). Sieving coefficient (SC) and clearance of all the above-mentioned solutes were calculated based on the measured data. Results:The SCs of Aspartate acid and Glumatic acid were (0. 5 + 0. 04 ) and ( 0. 48 + 0. 07 ), respectively ; and the SCs of other 10 amino acids were nearly 0. 9. During various dose and mode, clearances of UN and Cr were comparable. With the dose of 2 000 mL/h, theclearances of UN/Cr under the CVVHD,Pre-CVVH, post-CVVH modes were 32. 7/32. 68 ml/min,23.95/24. 69 ml/min, 32. 62/32.22 ml/min, respectively ;while with the dose of 4 000 ml/h, the clearances of UN/Cr under the CVVHD, Pre- CVVH, post-CVVH modes were 62. 73/63.31 ml/min ,45.59/48.09 ml/min, and 65.16/66.41 ml/min, respectively. In all modes and doses, the clearance of Aspartic acid and Glumatic acid was much lower than other 10 amino acids, but without obvious differences of clearance between the 10 amino acids. With the dose of 2 000 ml/h, the clearances of Aspartate acid/ Glumatic acid under the CVVHD, Pre-CVVH, post-CVVH modes were 18. 08/16. 79 ml/min, 13.39/13.33 ml/min and 19. 1/19. 6 ml/min, respectively;while the clearance of other 10 amino acids were 28.31 -32. 18 ml/min,21.6 -24.9 mlf min and 27. 38 -32. 4 ml/min, respectively. With the dose of 4 000 ml/hr,the clearances of Aspartate aeid/Glumatic acid under the CVVHD, Pre-CVVH, post-CVVH modes were 36.95/32. 88 mL/min, 29.37/26. 86 ml/min and 37. 82/34. 79 ml/min, respectively ;while the clearance of other 10 amino acids were 59. 18 -64. 8 ml/min, 46. 71 -50. 64 ml/min and 58. 83 - 65.1 ml/min, respectively. Conehlsion:The mode of CRRT has an impact on the clearance of amino acids, but the effects of CRRT dose are more dominant.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2012年第3期223-227,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 国家自然科学基金项目(81070608)
关键词 连续性肾脏替代治疗 氨基酸 清除率 continuous renal replacement therapy amino acids clearances
  • 相关文献

参考文献19

  • 1Liangos O,Wald R,O' Bell JW. Epidemiology and outcomes of acute renal failure in hospitalized patients:a national survey[J].Clin J Am Soc Nephrol,2006,(01):43-51.
  • 2Ronco C,Bellomo R,Homel P. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure:a prospective randomised trial[J].Lancet,2000,(9223):26-30.
  • 3Cole L,Bellomo R,Journois D. High-volume haemofiltration in human septic shock[J].Intensive Care Medicine,2001,(06):978-986.
  • 4Druml W. Nutritional management of acute renal failure[J].Journal of Renal Nutrition,2005,(01):63-70.
  • 5Ikizler TA,Flakoll PJ,Parker RA,el at. Amino acid and albumin losses during hemodialysis[J].Kidney International,1994,(03):830-837.
  • 6Frankenfield DC,Badellino MM,Reynolds HN,el at. Amino acid loss and plasma concentration during continuous hemodiafiltration[J].Journal of Parenteral and Enteral Nutrition,1993,(06):551-561.
  • 7龚德华,季大玺,谢红浪,徐斌,刘芸,黎磊石.不同CRRT方式对溶质清除的影响[J].肾脏病与透析肾移植杂志,2000,9(6):530-533. 被引量:29
  • 8Davies SP,Reaveley DA,Brown EA,el at. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis[J].Critical Care Medicine,1991,(12):1510-1515.
  • 9Maxvold NJ,Smoyer WE,Custer JR,el at. Amino acid loss and nitrogen balance in critically ill children with acute renal failure:a prospective comparison between classic hemofiltration and hemofiltration with dialysis[J].Critical Care Medicine,2000,(04):1161-1165.
  • 10Davenport A,Roberts NB. Amino acid losses during continuous highflux hemofiltration in the critically ill patient[J].Critical Care Medicine,1989,(10):1010-1014.

二级参考文献3

共引文献28

同被引文献65

  • 1李科慧,周红卫,史应龙.连续性血液净化补充氨基酸对危重症患者血清氨基酸谱和细胞免疫功能的影响[J].中国老年学杂志,2014,34(8):2094-2096. 被引量:14
  • 2谢红浪,季大玺.不同透析膜的生物特性及临床应用[J].肾脏病与透析肾移植杂志,2004,13(4):374-377. 被引量:22
  • 3Hong-Li Jiang,Wu-Jun Xue,Da-Qing Li,Ai-Ping Yin,Xia Xin,Chun-Mei Li,Ju-Lin Gao.Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis[J].World Journal of Gastroenterology,2005,11(31):4815-4821. 被引量:63
  • 4张延龄,吴肇汉.实用外科学[M].第3版.北京:人民卫生出版社.2012.1164.
  • 5Giuliani E,Coppi F,Bertolotti V,et al.Critical Illness in Energy Metabolism Genetic Disorder:RhabdomyoIysis,Acute Kidney Injury,Respiratory Arrest[J].West Indian Med J,2013,62(8):773-775.
  • 6Xiao Yue,Sui Bin-yan,Zhao Kun.Application of end-stage renal disease status and dialysis technology in China,cost and payment analysis of[J].Chinese health policy research,2011,4(5):29-33.
  • 7Zhou Quan-kang,Zhou Xiao-yan.Diabetes mellitus screening at Taopu town,Putuo District in Shanghai City and Medical intervention on the impaired glucose tolerance[J].Journal of Clinical research,2010,27(3):537-538.
  • 8Sun Zhi-qiang,Chen Bao-ping.Research progress of diabetic nephropathy[J].Chinese Journal of practical diagnosis and treatment,2010,24(6):539-541.
  • 9Xu Huan,Ni Hua-fang.Nursing care for maintenance hemodialysis patients with hypertension[J].Research and practice of Nursing,2011,8(2):87-88.
  • 10Peter G.Kerr International Differences in hemodialysis Delivery and Their Influence on Outcomes[J].American Journal of Kidney Diseases,2011,58(3):461-470.

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部